In the last few years, all eyes have turned to GLP-1s as an industry-altering answer to obesity treatment and weight management. But the fact is, these drugs can’t – and shouldn’t – work in a vacuum. There is a fear that attention on GLP-1s may even blind leaders to the other services that go into providing effective obesity care. So, what should leaders be thinking about when designing and and delivering effective obesity care?

To answer that question, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to unpack what comprehensive weight management programs look like in practice, and why—if done well— they can benefit patients, clinicians, and health systems.

Links:

Learn more about On-demand Courses

A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.